Biosimilars Market Size, Share, Trends, Growth and Forecast 2032

Biosimilars Market

Biosimilars Market- by Product (Recombinant non-glycosylated proteins, Recombinant peptides, Recombinant glycosylated proteins), by Manufacturing type (Contract manufacturing organizations, In-house manufacturing), by Application (Blood disorders, Growth hormone deficiency, Oncology, Chronic & autoimmune diseases, Infectious diseases, Others) - Global Industry Perspective Comprehensive Analysis and Forecast, 2024 - 2032

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-1290 Published Date: Oct-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 29.45 Billion USD 86.37 Billion 12.82% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Biosimilars Market, 2016 - 2026, (USD Billion)
    • 2.2. Biosimilars Market: Snapshot
  • Chapter 3. Global Biosimilars Market – Industry Analysis
    • 3.1. Biosimilars Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rising incidence of chronic diseases
      • 3.2.2. Increasing demand for biosimilar drugs
    • 3.3. Restraints
      • 3.3.1. Complexities in manufacturing
    • 3.4. Opportunity
      • 3.4.1. New indications and the patent expiry of biulogic products
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Product segment
      • 3.6.2. Market attractiveness analysis by Manufacturing type segment
      • 3.6.3. Market attractiveness analysis by Application segment
      • 3.6.4. Market attractiveness analysis by regional segment
  • Chapter 4. Global Biosimilars Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Biosimilars market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Manufacturing type launches
      • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Biosimilars Market – Product Segment Analysis
    • 5.1. Global Biosimilars market overview: by Product
      • 5.1.1. Global Biosimilars market revenue share, by Product, 2019 and 2026
    • 5.2. Recombinant non-glycosylated proteins
      • 5.2.1. Global Biosimilars market by Recombinant non-glycosylated proteins, 2016-2026 (USD Billion)
    • 5.3. Recombinant peptides
      • 5.3.1. Global Biosimilars market by Recombinant peptides, 2016-2026 (USD Billion)
    • 5.4. Recombinant glycosylated proteins
      • 5.4.1. Global Biosimilars market by Recombinant glycosylated proteins, 2016-2026 (USD Billion)
  • Chapter 6. Global Biosimilars Market – Manufacturing type Segment Analysis
    • 6.1. Global Biosimilars market overview: by Manufacturing type
      • 6.1.1. Global Biosimilars market revenue share, by Manufacturing type, 2019 and 2026
    • 6.2. Contract manufacturing organizations
      • 6.2.1. Global Biosimilars market by Contract manufacturing organizations, 2016-2026 (USD Billion)
    • 6.3. In-house manufacturing
      • 6.3.1. Global Biosimilars market by In-house manufacturing, 2016-2026 (USD Billion)
  • Chapter 7. Global Biosimilars Market – Application Segment Analysis
    • 7.1. Global Biosimilars market overview: by Application
      • 7.1.1. Global Biosimilars market revenue share, by Application, 2019 and 2026
    • 7.2. Blood disorders
      • 7.2.1. Global Biosimilars market by Blood disorders, 2016-2026 (USD Billion)
    • 7.3. Growth hormone deficiency
      • 7.3.1. Global Biosimilars market by Growth hormone deficiency, 2016-2026 (USD Billion)
    • 7.4. Onculogy
      • 7.4.1. Global Biosimilars market by Onculogy, 2016-2026 (USD Billion)
    • 7.5. Chronic & autoimmune diseases
      • 7.5.1. Global Biosimilars market by Chronic & autoimmune diseases, 2016-2026 (USD Billion)
    • 7.6. Infectious diseases
      • 7.6.1. Global Biosimilars market by Infectious diseases, 2016-2026 (USD Billion)
    • 7.7. Others
      • 7.7.1. Global Biosimilars market by Others, 2016-2026 (USD Billion)
  • Chapter 8. Global Biosimilars Market - Regional Analysis
    • 8.1. Global Biosimilars market overview: by region
      • 8.1.1. Global Biosimilars market revenue share, by region, 2019 and 2026
    • 8.2. North America
      • 8.2.1. North America Biosimilars market, by country, 2016-2026 (USD Billion)
      • 8.2.2. North America Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
      • 8.2.3. North America Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
      • 8.2.4. North America Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S. Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
        • 8.2.5.2. The U.S. Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
        • 8.2.5.3. The U.S. Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
        • 8.2.6.2. Rest of North America Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
        • 8.2.6.3. Rest of North America Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Biosimilars market, by country, 2016-2026 (USD Billion)
      • 8.3.2. Europe Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
      • 8.3.3. Europe Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
      • 8.3.4. Europe Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
      • 8.3.5. U.K.
        • 8.3.5.1. U.K. Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
        • 8.3.5.2. U.K. Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
        • 8.3.5.3. U.K. Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
        • 8.3.6.2. France Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
        • 8.3.6.3. France Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
        • 8.3.7.2. Germany Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
        • 8.3.7.3. Germany Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
        • 8.3.8.2. Rest of Europe Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
        • 8.3.8.3. Rest of Europe Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Biosimilars market, by country, 2016-2026 (USD Billion)
      • 8.4.2. Asia Pacific Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
      • 8.4.3. Asia Pacific Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
      • 8.4.4. Asia Pacific Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
      • 8.4.5. China
        • 8.4.5.1. China Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
        • 8.4.5.2. China Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
        • 8.4.5.3. China Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
        • 8.4.6.2. Japan Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
        • 8.4.6.3. Japan Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
      • 8.4.7. India
        • 8.4.7.1. India Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
        • 8.4.7.2. India Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
        • 8.4.7.3. India Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
        • 8.4.8.2. Rest of Asia Pacific Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
        • 8.4.8.3. Rest of Asia Pacific Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Biosimilars market, by country, 2016-2026 (USD Billion)
      • 8.5.2. Latin America Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
      • 8.5.3. Latin America Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
      • 8.5.4. Latin America Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
        • 8.5.5.2. Brazil Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
        • 8.5.5.3. Brazil Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
        • 8.5.6.2. Rest of Latin America Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
        • 8.5.6.3. Rest of Latin America Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
    • 8.6. Middle East & Africa
      • 8.6.1. Middle East & Africa Biosimilars market, 2016-2026 (USD Billion)
      • 8.6.2. Middle East & Africa Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
      • 8.6.3. Middle East & Africa Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
      • 8.6.4. Middle East & Africa Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
  • Chapter 9. Company Profiles
    • 9.1. Pfizer Inc.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Teva Pharmaceuticals Industries Ltd.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Biocon Ltd
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. F. Hoffmann-La Roche Ltd.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Samsung Bioepis
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. Sandoz International GmbH
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. Amgen Inc
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. Dr. Reddy’s Laboratories Ltd
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. Celltrion, Inc.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Biosimilars market, 2016-2026 (USD Billion)
4. Porter’s five forces analysis: Biosimilars market
5. Global Biosimilars market attractiveness, by Product
6. Global Biosimilars market attractiveness, by Manufacturing type
7. Global Biosimilars market attractiveness, by Application
8. Global Biosimilars market revenue share, by Product, 2019 and 2026
9. Global Biosimilars market by Recombinant non-glycosylated proteins, 2016-2026 (USD Billion)
10. Global Biosimilars market by Recombinant peptides, 2016-2026 (USD Billion)
11. Global Biosimilars market by Recombinant glycosylated proteins, 2016-2026 (USD Billion)
12. Global Biosimilars market revenue share, by Manufacturing type, 2019 and 2026
13. Global Biosimilars market by Contract manufacturing organizations, 2016-2026 (USD Billion)
14. Global Biosimilars market by In-house manufacturing, 2016-2026 (USD Billion)
15. Global Biosimilars market revenue share, by Application, 2019 and 2026
16. Global Biosimilars market by Blood disorders, 2016-2026 (USD Billion)
17. Global Biosimilars market by Growth hormone deficiency, 2016-2026 (USD Billion)
18. Global Biosimilars market by Growth hormone deficiency, 2016-2026 (USD Billion)
19. Global Biosimilars market by Oncology, 2016-2026 (USD Billion)
20. Global Biosimilars market by Chronic & autoimmune diseases, 2016-2026 (USD Billion)
21. Global Biosimilars market by Infectious diseases, 2016-2026 (USD Billion)
22. Global Biosimilars market by Others, 2016-2026 (USD Billion)
23. Global Biosimilars market revenue share, by region, 2018 & 2025
24. North America Biosimilars market, 2016-2026 (USD Billion)
25. Europe Biosimilars market, 2016-2026 (USD Billion)
26. Asia Pacific Biosimilars market, 2016-2026 (USD Billion)
27. Latin America Biosimilars market, 2016-2026 (USD Billion)
28. Middle East & Africa Biosimilars market, 2016-2026 (USD Billion)


Table Of Tables

List of Tables

1. Global Biosimilars market: snapshot
2. Drivers for Biosimilars market: impact analysis
3. Restraints for Biosimilars market: impact analysis
4. North America Biosimilars market revenue, by country, 2016-2026 (USD Billion)
5. North America Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
6. North America Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
7. North America Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
8. The U.S. Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
9. The U.S. Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
10. The U.S. Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
11. Rest of North America Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
12. Rest of North America Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
13. Rest of North America Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
14. Europe Biosimilars market revenue, by country, 2016-2026 (USD Billion)
15. Europe Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
16. Europe Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
17. Europe Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
18. U.K. Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
19. U.K. Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
20. U.K. Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
21. France Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
22. France Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
23. France Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
24. Germany Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
25. Germany Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
26. Germany Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
27. Rest of Europe Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
28. Rest of Europe Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
29. Rest of Europe Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
30. Asia Pacific Biosimilars market revenue, by country, 2016-2026 (USD Billion)
31. Asia Pacific Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
32. Asia Pacific Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
33. Asia Pacific Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
34. China Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
35. China Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
36. China Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
37. Japan Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
38. Japan Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
39. Japan Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
40. India Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
41. India Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
42. India Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
43. Rest of Asia Pacific Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
44. Rest of Asia Pacific Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
45. Rest of Asia Pacific Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
46. Latin America Biosimilars market revenue, by country, 2016-2026 (USD Billion)
47. Latin America Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
48. Latin America Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
49. Latin America Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
50. Brazil Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
51. Brazil Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
52. Brazil Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
53. Rest of Latin America Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
54. Rest of Latin America Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
55. Rest of Latin America Biosimilars market revenue, by Application, 2016-2026 (USD Billion)
56. Middle East & Africa Biosimilars market revenue, by Product, 2016-2026 (USD Billion)
57. Middle East & Africa Biosimilars market revenue, by Manufacturing type, 2016-2026 (USD Billion)
58. Middle East & Africa Biosimilars market revenue, by Application, 2016-2026 (USD Billion)


 

Methodology

FrequentlyAsked Questions

Biosimilar is a biopharmaceutical product that is similar to the previous or the original existing product that is manufactured by a company. The biosimilar also has alternative names such as subsequent entry biologic or follow-on biologic.

The major factor that contributed to the biosimilar market growth is the emergence of biologic products that are off-patent. These drugs are very cost-effective thus making their demand increase substantially.

According to a study, the global biosimilar Industry size was $29.45 Billion in 2023 and is projected to reach $86.37 Billion by the end of 2032.

The global biosimilar market is expected to grow at a CAGR of 12.82% during the forecast period.

The key market players in the biosimilars market include Pfizer Inc., Teva Pharmaceuticals Industries Ltd., Biocon Ltd., F. Hoffmann-La Roche Ltd., Samsung Bioepis, Sandoz International GmbH, Amgen Inc., Dr. Reddy’s Laboratories Ltd., and Celltrion, Inc

The global biosimilar market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.

Choose License Type

  • zion payment modes

List of Contents

Biosimilars Market InsightsGlobal Biosimilars OverviewGlobal Biosimilars SegmentationGlobal Biosimilars Growth FactorsBiosimilars Report ScopeGlobal Biosimilars Regional AnalysisGlobal Biosimilars Competitive PlayersGlobal Biosimilars Treatment Product Segment AnalysisGlobal Biosimilars Treatment Manufacturing Type Segment AnalysisGlobal Biosimilars Treatment Application Segment Analysis Global Biosimilars Regional Segment Analysis

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed